InsiderDB

Lobbying disclosures · Lobbying report

CAH: third_quarter 2026 lobbying report

Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to prov

Follow CAH
Became public
Oct 20, 2026, 1:54 PM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 4:37 PM EST

Why this is connected

Exact legal-name match: CARDINAL HEALTH INC (https://www.sec.gov/Archives/edgar/data/721371/).

Reported lobbying amounts

Expenses: $400,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/a6ff9ec2-1ac2-45a1-a0b2-de9be14e616a/","filing_uuid":"a6ff9ec2-1ac2-45a1-a0b2-de9be14e616a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a6ff9ec2-1ac2-45a1-a0b2-de9be14e616a/print/","filing_document_content_type":"text/html","income":null,"expenses":"400000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Rebecca McGrath","dt_posted":"2026-10-20T13:54:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"7000 CARDINAL PLACE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"DUBLIN","registrant_state":"OH","registrant_zip":"43017","registrant":{"id":58055,"url":"https://lda.gov/api/v1/registrants/58055/","house_registrant_id":35261,"name":"CARDINAL HEALTH, INC.","description":null,"address_1":"7000 CARDINAL PLACE","address_2":null,"address_3":null,"address_4":null,"city":"DUBLIN","state":"OH","state_display":"Ohio","zip":"43017","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"REBECCA MCGRATH","contact_telephone":"+1 202-258-3789","dt_updated":"2026-07-30T08:49:35.442205-04:00"},"client":{"id":160433,"url":"https://lda.gov/api/v1/clients/160433/","client_id":12,"name":"CARDINAL HEALTH INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs, trade, and U.S. trade policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64174,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"MCGRATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138467,"prefix":"ms","prefix_display":"MS.","first_name":"ANGELEINE","nickname":null,"middle_name":null,"last_name":"COMTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140381,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"BARNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155609,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"HEALEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in CAH

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.